Buy Cadonilimab Injection in India

Cadonilimab

Generic Name/API:Cadonilimab
Packaging:1 vial per box
Storage:Store refrigerated at 2°C to 8°C, protected from light
Dosage:For dosage information, please check the General Information section.
Strength:125 mg (10 mL)/bottle
Indication:The specific, approved clinical indications for Cadonilimab include: Cervical Cancer: Indicated for persistent, recurrent, or metastatic cases, particularly for patients who have progressed on platinum-based chemotherapy, including as a first-line treatment in combination with chemotherapy. G/GEJ Adenocarcinoma: Approved for locally advanced unresectable or metastatic cases in combination with chemotherapy

Cadonilimab is a novel, first-in-class PD-1/CTLA-4 bi-specific immunotherapy drug. Cadonilimab was granted marketing approval by the NMPA of China for the treatment of relapsed or metastatic cervical cancer (R/M CC) patients who progressed on or after platinum-based chemotherapy malignant tumors on June 29th, 2022.

In September 2024, Cadonilimab was approved for first-line treatment of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinoma, in combination with fluoropyrimidine and platinum-based chemotherapy

In May 2025, Cadonilimab was approved for the first-line treatment of persistent, recurrent, or metastatic cervical cancer, in combination with platinum-based chemotherapy, with or without bevacizumab. All the above-approved indications are included in China’s latest National Reimbursement Drug List (NRDL).

STRENGTH:

125 mg (10 mL)/bottle

DOSAGE: 

Recurrent/Metastatic Cervical Cancer

  • 6 mg/kg IV infusion every 2 weeks (Q2W) until disease progression, unacceptable toxicity, or treatment discontinuation. 

First-line Gastric/Gastroesophageal Junction Adenocarcinoma

  • 10 mg/kg IV infusion every 3 weeks (Q3W).

ADVERSE REACTIONS:

  • Most common Treatment-related adverse events (TRAEs) (Any Grade, incidence ≥ 10%): anemia, 37(33.3%); hypothyroidism, 22(19.8%); alanine aminotransferase increased, 20(18.0%).
  • Most common ≥3 Grade TRAEs (incidence ≥ 1%): anemia, 6(5.4%); decreases appetite, 3(2.7%); dyspnea.
  • Most common Immune-mediated adverse events (irAEs) (Any Grade, incidence ≥ 1%): hypothyroidism, 15(13.5%); hyperthyroidism, 13(11.7%); blood thyroid stimulating hormone decreased, 4(3.6%). 
  • Most common irAEs (≥3 Grade): immune-mediated pneumonitis, 1(0.9%); hyperthyroidism, 1(0.9%); myocarditis, 1(0.9%); myositis, 1(0.9%); hepatitis, 1(0.9%); thrombocytopenia, (0.9%); diarrhea, 1(0.9%).

STORAGE: 

Store refrigerated at 2°C to 8°C , protected from light.

Immune-Related Adverse Events (irAEs): Because cadonilimab enhances the immune system, it can cause severe or fatal inflammation in various organs. This most commonly includes the lungs, liver, intestines, endocrine system and kidneys.

Symptoms to Monitor and Report

Always seek immediate medical attention if you experience any of the following toxicity warning signs:

  • Colitis (Intestines): Severe abdominal pain, diarrhea or blood in the stool.
  • Pneumonitis (Lungs): New or worsening cough, chest pain or shortness of breath.
  • Hepatitis (Liver): Yellowing of the skin or eyes (jaundice), severe nausea or dark urine.
  • Endocrinopathies: Extreme fatigue, headache, dizziness, rapid heart rate, weight changes or changes in mood/behavior.
  • Severe Skin Reactions: Rash, blistering or peeling skin

Import Cadonilimab in India through Named Patient Program

FAQ

  • What is Cadonilimab?
  • What are the targets of Cadonilimab?
  • How is Cadonilimab administered?
  • What should clinicians do if severe immune-related toxicity develops?
  • Is Cadonilimab Injection approved worldwide?
  • What is the cost of Cadonilimab Injection in India?
  • How to Buy Cadonilimab Injection online in India?
  • Can Cadonilimab Injection be imported into India?
What is Cadonilimab?

Cadonilimab is a PD-1/CTLA-4 bispecific antibody designed to simultaneously block two immune checkpoint pathways and enhance antitumor immune responses.

What are the targets of Cadonilimab?

Cadonilimab targets PD-1 (Programmed Death-1) and CTLA-4 (Cytotoxic T-Lymphocyte Antigen-4). By blocking both pathways, it helps activate T-cells and improve the body’s immune response against cancer cells.

How is Cadonilimab administered?

Cadonilimab is administered as an intravenous (IV) infusion under the supervision of qualified healthcare professionals. The dosage and treatment schedule are determined by the treating physician.

What should clinicians do if severe immune-related toxicity develops?

Treatment interruption, corticosteroids and other immunosuppressive measures may be required depending on severity and local treatment guidelines.

Is Cadonilimab Injection approved worldwide?

No, Cadonilimab Injection approvals vary by country and indication. Healthcare professionals should consult local prescribing information and regulatory authorities for the latest approval status.

What is the cost of Cadonilimab Injection in India?

The cost of Cadonilimab Injection online in India depends on dosage, sourcing and import requirements. For the latest Cadonilimab price in India, contact 24/7 QualityMeds at +91 99679 79080.

How to Buy Cadonilimab Injection online in India?

Patients can Buy Cadonilimab Injection online in India through authorized import channels such as the Named Patient Program (NPP). 24/7 QualityMeds assists with documentation, sourcing and import procedures.

Can Cadonilimab Injection be imported into India?

Yes, Cadonilimab Injection can be imported into India through legal pathways such as the Named Patient Program, subject to a valid prescription and required medical documentation.

"I am very happy with experience of delivery medicine! From start to finish, everything was smooth, professional, and exceeded my expectations. The coordinator was incredibly responsive and friendly, and the product itself best in condition exactly as described. Delivery was fast, packaging was secure, and I felt truly valued as a customer. I'll be coming back and recommending this to friends and family. Once again Thanks for delivering medicine with in 24 hours which help my wife to start treatment on time. "

- Mr. Sanjay More

"I've been using this medicine delivery service for a few months now, and I couldn't be happier. The ordering process is simple and user-friendly, and the delivery is always prompt and reliable. I especially appreciate the timely updates, which help me stay on track with my prescriptions. The coordinator team is responsive and genuinely helpful, always ready to answer questions or resolve any issues. The packaging is secure, and the medicines always arrive in perfect condition. This service has made managing my health so much easier and stress-free. Highly recommended for anyone looking for convenience, reliability, and great customer care! "

- Mr. Nilesh Patankar

"I'm really impressed with the level of service. From placing the order to receiving the medicines, everything is smooth and hassle-free. The coordinator even called several times for updates my package. It's rare to find such thoughtful service these days!"

- Mr. Mohit Vishwakarma

About us

We're a dedicated team of medicine access experts, doctors and pharmacists. We come from all over the world. And we've lost family and friends who could not get the medicine they needed because they lived in the wrong country.

Our mission is to get everyone the right treatment at the right time. Wherever you live. Because you should not suffer or die if a treatment that could help you exists somewhere.

Learn more ›

If you have any questions or need help, we're a phone call away. Our team is available from Monday to Friday between 9 a.m and 6 p.m CET

We usually respond to emails within 24 working hours

Worldwide Delivery

India

Mumbai, Delhi, Bengaluru, Hyderabad, Chennai, Kolkata, Pune, Ahmedabad, Surat, Jaipur, Lucknow, Noida, Gurugram, Chandigarh, Kochi, Coimbatore, Indore, Bhopal, Visakhapatnam, Vijayawada, Patna, Ranchi, Raipur, Bhubaneswar, Guwahati, Amritsar, Ludhiana, Jodhpur, Dehradun, Srinagar, Jammu, Siliguri, Mysuru, Nagpur, Nashik, Vadodara, Thiruvananthapuram, Cuttack, Warangal, Gangtok, Leh, Kargil, Puducherry, Karaikal, Port Blair, Daman, Silvassa, Kavaratti, Thane, Mangaluru, Nizamabad, Madurai, Rajkot, Udaipur, Kanpur, Kozhikode, Tirupati, Gwalior, Muzaffarpur, Durgapur, Rourkela, Jalandhar, Panipat, Durg-Bhilai, Dhanbad, Silchar, Haldwani, Anantnag, Solan, Vasco da Gama, Pakyong, Agartala, Imphal, Shillong, Dimapur, Aizawl, Itanagar, Yanam, Diu, Dadra.

Asia-Pacific (APAC)

Afghanistan, Australia, Bangladesh, Bhutan, Brunei, Cambodia, China, Christmas Island, Cocos (Keeling) Islands, Cook Islands, Fiji, French Polynesia, Guam, Hong Kong SAR China, Indonesia, Japan, Kazakhstan, Kiribati, Kyrgyzstan, Laos, Macao SAR China, Malaysia, Maldives, Marshall Islands, Micronesia, Mongolia, Myanmar (Burma), Nauru, Nepal, New Caledonia, New Zealand, Niue, Norfolk Island, North Korea, Northern Mariana Islands, Pakistan, Palau, Papua New Guinea, Philippines, Pitcairn Islands, Samoa, Singapore, Solomon Islands, South Korea, Sri Lanka, Taiwan, Tajikistan, Thailand, Timor-Leste, Tokelau, Tonga, Turkmenistan, Tuvalu, Uzbekistan, Vanuatu, Vietnam, Wallis & Futuna.

Middle East

Bahrain, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Palestinian Territories, Qatar, Saudi Arabia, Syria, Turkey, United Arab Emirates, Yemen.

Europe

Albania, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia & Herzegovina, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Faroe Islands, Finland, France, Georgia, Germany, Gibraltar, Greece, Guernsey, Hungary, Iceland, Ireland, Isle of Man, Italy, Jersey, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Moldova, Monaco, Montenegro, Netherlands, North Macedonia, Norway, Poland, Portugal, Romania, Russia, San Marino, Serbia, Slovakia, Slovenia, Spain, Svalbard & Jan Mayen, Sweden, Switzerland, Ukraine, United Kingdom, Vatican City, Åland Islands.

North America

Antigua & Barbuda, Bahamas, Barbados, Belize, Bermuda, British Virgin Islands, Canada, Cayman Islands, Costa Rica, Cuba, Dominica, Dominican Republic, El Salvador, Greenland, Grenada, Guadeloupe, Guatemala, Haiti, Honduras, Jamaica, Martinique, Mexico, Montserrat, Nicaragua, Panama, Puerto Rico, St. Barthélemy, St. Kitts & Nevis, St. Lucia, St. Martin, St. Pierre & Miquelon, St. Vincent & Grenadines, Trinidad & Tobago, Turks & Caicos Islands, United States, U.S. Virgin Islands.

South America

Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela.

Africa

Algeria, Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Congo - Brazzaville, Congo - Kinshasa, Côte d'Ivoire, Djibouti, Egypt, Equatorial Guinea, Eritrea, Eswatini, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mayotte, Morocco, Mozambique, Namibia, Niger, Nigeria, Réunion, Rwanda, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, St. Helena, Sudan, Tanzania, Togo, Tunisia, Uganda, Western Sahara, Zambia, Zimbabwe.

Caribbean Islands

Anguilla, Antigua & Barbuda, Aruba, Bahamas, Barbados, Bermuda, British Virgin Islands, Cayman Islands, Cuba, Dominica, Dominican Republic, Grenada, Guadeloupe, Haiti, Jamaica, Martinique, Montserrat, St. Barthélemy, St. Kitts & Nevis, St. Lucia, St. Martin, St. Pierre & Miquelon, St. Vincent & Grenadines, Trinidad & Tobago, Turks & Caicos Islands, U.S. Virgin Islands.

Disclaimer

All trademarks, logos, brand names, and product names appearing on this website are the property of their respective owners. 247qualitymeds.com does not claim any ownership or affiliation with these trademarks or brands. They are used solely for informational and reference purposes to help users identify products and understand their intended use. The presence of any trademark or brand name on this website does not imply endorsement, sponsorship, or association with 247qualitymeds.com in any form.